AbbVie
ABBV
#25
Rank
$404.21 B
Marketcap
$228.71
Share price
-0.66%
Change (1 day)
33.18%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total debt

Total debt on the balance sheet as of September 2025 : $68.74 Billion USD

According to AbbVie's latest financial reports the company's total debt is $68.74 Billion USD. A companyโ€™s total debt is the sum of all current and non-current debts.

AbbVie - Total debt on balance sheet (from 2011 to 2025)

Total debt by year

Year Total debt Change
2024-12-31$67.14 B13.07%
2023-12-31$59.38 B-6.14%
2022-12-31$63.27 B-17.49%
2021-12-31$76.68 B-10.89%
2020-12-31$86.05 B28.97%
2019-12-31$66.72 B65.54%
2018-12-31$40.31 B7.87%
2017-12-31$37.36 B1.43%
2016-12-31$36.84 B16.33%
2015-12-31$31.67 B111.46%
2014-12-31$14.97 B1.73%
2013-12-31$14.72 B-6.06%
2012-12-31$15.67 B32550%
2011-12-31$48 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Pfizer
PFE
$60.84 B-11.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
$51.04 B-25.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
$42.50 B-38.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$54.58 B-20.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
$24.94 B-63.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Biogen
BIIB
$6.59 B-90.41%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$23.86 B-65.29%๐Ÿ‡ฌ๐Ÿ‡ง UK
AstraZeneca
AZN
$32.63 B-52.53%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
$0.42 B-99.38%๐Ÿ‡บ๐Ÿ‡ธ USA